Facebook Instagram Linkedin Twitter Youtube
Friday, November 22, 2024
Facebook Instagram Linkedin Twitter Youtube
Advertise With Us
Home Tags Fasenra China Approval

Tag: Fasenra China Approval

AstraZeneca Fasenra approved in China for treating severe eosinophilic asthma, featuring an image of lungs and the medication.
Health

China Approves AstraZeneca’s Fasenra for Severe Eosinophilic Asthma

John - 0
AstraZeneca's Fasenra (benralizumab) has been approved by China's National Medical Products Association (NMPA) for the treatment of severe eosinophilic asthma in patients aged 12...
15,925FansLike
1,951FollowersFollow
155SubscribersSubscribe
Global Market Updates

EDITOR PICKS

Global Market Updates
We delivers reliable, timely news across various categories including lifestyle, health, business, tech, and more. Stay informed with us and explore a world of knowledge!
Facebook Instagram Linkedin Twitter Youtube

EVEN MORE NEWS

POPULAR CATEGORY

© Global Market Updates